What is the Projected CAGR value of the Cancer Molecular Diagnostics Market?
The Cancer Molecular Diagnostics market is expected to grow at a CAGR of 6.30% during the forecast period 2024-2031.
Who are the key players in Cancer Molecular Diagnostics Market?
Key Players are Abbott Laboratories, Bayer Healthcare, Becton Dickinson, Cepheid, Dako, Danaher Corporation, Qiagen N.V., Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Beckman Coulter, bioMérieux, bioTheranostics, Genera Biosystems, Genomic Health, Genomix Biotech, Nuvera Bioscience and Orion Genomics.